Experience

H1

• United States
• Software Development
• 300 - 400 Employee

• Senior Sales Engineer

  • Apr 2022 - Present



Calithera Biosciences

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Associate Director Medical Affairs

  • Jan 2021 - Apr 2022

  •Designed Medical Communications assets and Media Plan to support the KEAPSAKE trial, increasing patient referrals to trial sites and improving patient screening rates.•Moderated KEAPSAKE trial accrual workshop webinars for study sites, boosting trial enrollment.• Identified changes in 1L NSCLC treatment patterns during the COVID-19 pandemic, using innovative patient journey analysis, maximizing data-driven strategies to drive KEAPSAKE trial recruitment.•Established a strong relationship with Emily’s Entourage, a patient advocacy group focused on Cystic Fibrosis (CF) patients harboring rare deletion mutations: which resulted in sponsorship opportunities and an internal company event with Emily, increasing the patient connection for employees working on the CF program. Show less

• Senior Medical Science Liaison

  • Feb 2018 - Jan 2021

  •Boosted enrollment of the CANTATA trial, Calithera’s pivotal registrational trial in mRCC, ensuring it met its early enrollment timeline goal.•Presented Calithera Pipeline at the 2019 Big Ten Cancer Research Consortium Summit, resulting in multiple new investigators joining company-sponsored studies and a new relationship with the Lung-MAP leadership committee, with which Calithera had previously had a difficult time engaging.•Led KOL mapping and field insight analytics, resulting in focused field strategies for RCC KOL engagement and in strengthening the identification of actionable insights to inform cross-functional strategic choices.• Co-led Medical Affairs pre-launch strategy initiative planning, resulting in an approved operational plan and priorities for the annual budget planning cycle.•Developed and moderated the novel “Key Highlights of Onco-metabolism” KOL educational webinar, which resulted in engagement with clinicians that were previously inaccessible during the COVID-19 pandemic. • Represented Calithera in the “Digital Medical Insights in the Time of COVID-19” Medical Affairs Professional Society webinar, which highlighted Calithera Medical Affairs as a leader in innovative strategies for KOL engagement during the pandemic. •Highlighted Calithera’s pioneering work in Tumor Metabolism through KCCure, a kidney cancer patient advocacy group (https://kccure.org/2019/02/kccure-making-a-difference-calithera-biosciences/) Show less



Merck

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Medical Science Liaison

  • Mar 2016 - Feb 2018

  Health Systems Oncology Medical Affairs Director, 2017-2018 •Delivered on-label presentations including pipeline products in support of formulary decisions at payor organizations and state society meetings, resulting in favorable formulary coverage with key payors. Medical Science Liaison-Oncology, 2016-2017 •Led the Medical Affairs field team activities (16 OMADs) within the top 10 national diagnostic and biomarker reference labs to prepare for launch readiness in various tumor types and biomarkers. •Developed, in collaboration with the US Medical Affairs Strategy Lead, the 2016 Biomarker field-team strategy plan for pembrolizumab (Keytruda) in NSCLC and Melanoma. •Successfully led multiple novel projects that were recognized as above and beyond job expectations: Precision Medicine Initiative Lead, Biomarker Matrix Team Lead, New Hire Onboarding Partner, and MSI-H Subject Matter Expert. •Recipient of Award for Excellence by Oncology Global Medical Affairs leadership for work as MSI-high faculty member. •Awarded a Special Achievement Award at the Global U.S. Medical Affairs National Meeting (Berlin, Germany) for accelerating field team scientific expertise as NSCLC faculty member and Biomarker Matrix Team Lead. Show less



University of Minnesota

• United States
• Higher Education
• 700 & Above Employee

• Postdoctoral Research Associate

  • Aug 2015 - Mar 2016



The Ohio State University Wexner Medical Center

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Graduate Research Fellow

  • Jul 2011 - Aug 2015



Elon University

• United States
• Higher Education
• 700 & Above Employee

• Teaching Assistant

  • 2009 - 2011



Boehringer Ingelheim

• Germany
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Summer Research Intern

  • Jun 2010 - Aug 2010